<Disease><Name>DYSTONIA, DOPA-RESPONSIVE; DRD</Name><Synonym>SEGAWA SYNDROME; DYSTONIA, PROGRESSIVE, WITH DIURNAL VARIATIONS</Synonym><OMIM><Number>128230</Number><URL>http://omim.org/entry/128230</URL></OMIM><Orphanet><Number>98808</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=98808</URL></Orphanet><Protein><Number>GTP cyclohydrolase 1</Number><URL>http://www.uniprot.org/uniprot/P30793</URL></Protein><ExPASy><Number>3.5.4.16</Number><URL>http://enzyme.expasy.org/EC/3.5.4.16</URL></ExPASy><Gene>14q22.2</Gene><ICD>G24.1</ICD><Summary>rare (&gt;400 cases) ;autosomal dominant</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>4028</id><symptom>attention deficit disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3801</id><symptom>behavior, aggressive</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1948</id><symptom>defect of walking, running, rising or climbing</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3624</id><symptom>diurnal fluctuation of symptom</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2457</id><symptom>dyskinesia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2163</id><symptom>dysphagia</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3180</id><symptom>hand and/or feet deformities</symptom><category>SKELETAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2261</id><symptom>hyperreflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2631</id><symptom>hypersalivation</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>3627</id><symptom>hypokinesia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3311</id><symptom>Parkinsonism</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1919</id><symptom>progressive neurologic defect</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1773</id><symptom>ptosis (drooping eyelid)</symptom><category>EYES</category></symtomp><symtomp><id>3335</id><symptom>scoliosis</symptom><category>BODY | SKELETAL DEFECT</category></symtomp><symtomp><id>2142</id><symptom>swallowing difficulties</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3315</id><symptom>temperature instability</symptom><category>GENERAL TOPICS | GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1834</id><symptom>torticollis</symptom><category>BODY</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1624</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>1.80</min><max>12.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1652</id><name>Phenylalanine</name><specimen>urine</specimen><value /><min>3.50</min><max>11.20</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1781</id><name>Phenylalanine</name><specimen>urine</specimen><value /><min>0.00</min><max>120.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1837</id><name>Neopterin</name><specimen>urine</specimen><value /><min>0.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>1961</id><name>Phenylalanine</name><specimen>blood</specimen><value /><min>0.00</min><max>120.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1962</id><name>Phenylalanine</name><specimen>plasma</specimen><value>normal</value><min>34.00</min><max>86.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>2089</id><name>Biopterin</name><specimen>urine</specimen><value>normal</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>2090</id><name>Biopterin</name><specimen>urine</specimen><value>normal</value><min>0.50</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>1387</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>normal</value><min>0.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>910</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>120.00</min><max>500.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>931</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>105.00</min><max>299.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1001</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>    </min><max>11.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1388</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>0.20</min><max>8.70</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>424</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>425</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>426</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>934</id><name>Biopterin</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>10.00</min><max>50.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>684</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>3.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>685</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>686</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>6.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>687</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>1.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>688</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2022</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>911</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>100.00</min><max>900.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>932</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>211.00</min><max>871.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1919</id><name>Phenylalanine</name><specimen>urine</specimen><value>decreased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>422</id><name>Neopterin</name><specimen>urine</specimen><value>decreased</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1054</id><name>Neopterin</name><specimen>urine</specimen><value>decreased</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>423</id><name>Neopterin</name><specimen>urine</specimen><value>decreased</value><min>1.10</min><max>4.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>427</id><name>Neopterin</name><specimen>urine</specimen><value>decreased</value><min>0.20</min><max>1.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>935</id><name>Neopterin</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>9.00</min><max>20.00</max><unit>nmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1055</id><name>Neopterin</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>9.00</min><max>40.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>1548</id><name>Phenylalanine</name><specimen>urine</specimen><value>decreased</value><min>5.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>156</id><name>Phenylalanine</name><specimen>urine</specimen><value>decreased</value><min>4.00</min><max>32.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>871</id><name>Phenylalanine</name><specimen>urine</specimen><value>decreased</value><min>6.00</min><max>31.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1513</id><name>Phenylalanine</name><specimen>urine</specimen><value>decreased</value><min>7.00</min><max>28.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>52</id><name>Phenylalanine</name><specimen>plasma</specimen><value>normal</value><min>21.00</min><max>137.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>930</id><name>Phenylalanine</name><specimen>cerebrospinal fluid</specimen><value>normal</value><min>0.00</min><max>20.00</max><unit>&#956;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1057</id><name>Phenylalanine</name><specimen>plasma</specimen><value>normal</value><min>35.00</min><max>85.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1294</id><name>Phenylalanine</name><specimen>plasma</specimen><value>normal</value><min>26.00</min><max>85.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>1295</id><name>Phenylalanine</name><specimen>plasma</specimen><value>normal</value><min>26.00</min><max>98.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1306</id><name>Phenylalanine/Tyrosine</name><specimen>serum</specimen><value>normal</value><min>0.20</min><max>1.21</max><unit>ratio</unit><age>newborn</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7570</id><title>GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia</title><author>Furukawa Y</author><journal>Source  GeneReviews&#174; [Internet]</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>3711</id><title>Diagnosing dopamine-responsive dystonias</title><author>Malek N,</author><journal>Pract Neurol</journal><year>2015</year><book /><volume>15</volume><number>5</number><pages>340-345</pages><co_aut>Fletcher N, Newman E</co_aut></literature><literature><id>3712</id><title>Dopa-responsive dystonia--clinical and genetic heterogeneity</title><author>Wijemanne S,</author><journal>Nat Rev Neurol</journal><year>2015</year><book /><volume>11</volume><number>7</number><pages>414-424</pages><co_aut>Jankovic J</co_aut></literature><literature><id>3713</id><title>Hereditary progressive dystonia with marked diurnal fluctuation</title><author>Segawa M</author><journal>Brain Dev</journal><year>2011</year><book /><volume>33</volume><number>3</number><pages>195-201</pages><co_aut /></literature><literature><id>6002</id><title>Autosomal-dominant guanosine triphosphate cyclohydrolase I deficiency with novel mutations</title><author>Yum MS,</author><journal>Pediatr Neurol</journal><year>2008</year><book /><volume>38</volume><number>5</number><pages>367-369</pages><co_aut>et al.</co_aut></literature><literature><id>2048</id><title>Wide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH</title><author>Uncini A</author><journal>Mov Disord</journal><year>2004</year><book /><volume>19</volume><number>10</number><pages>1139-1145</pages><co_aut>et al.</co_aut></literature><literature><id>2049</id><title>A novel missense mutation of the GTP cyclohydrolase I gene in a Korean family with hereditary progressive dystonia/dopa-respons</title><author>Kang JH</author><journal>Brain Dev</journal><year>2004</year><book /><volume>26</volume><number>5</number><pages>2787-291</pages><co_aut>et al.</co_aut></literature><literature><id>2050</id><title>The hph-1 mouse: a model for dominantly inherited GTP-cyclohydrolase deficiency</title><author>Hyland K</author><journal>Ann Neurol Suppl</journal><year>2004</year><book /><volume>54</volume><number>0</number><pages>S46-48</pages><co_aut>et al.</co_aut></literature><literature><id>2052</id><title>Pediatric neurotransmitter diseases</title><author>Pearl PL</author><journal>Curr Neurol Neurosci Rep</journal><year>2004</year><book /><volume>4</volume><number>2</number><pages>147-152</pages><co_aut>Wallis DD, Gibson KM</co_aut></literature><literature><id>2053</id><title>Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease)</title><author>Segawa M</author><journal>Ann Neurol Suppl</journal><year>2003</year><book /><volume>54</volume><number>6</number><pages>S32-45</pages><co_aut>Nomura Y, Nishiyama N</co_aut></literature><literature><id>2051</id><title>Mutations of GCH1 in Dopa-responsive dystonia</title><author>Muller U</author><journal>J Neural Transm</journal><year>2002</year><book /><volume>109</volume><number>3</number><pages>321-328</pages><co_aut>Steinberger D, Topka H</co_aut></literature><literature><id>972</id><title>A novel mutation of the GTP-cyclohydrolase I gene in a patient with hereditary progressive dystonia/dopa-responsive dystonia</title><author>Imaiso Y</author><journal>Neurology</journal><year>1998</year><book /><volume>50</volume><number>0</number><pages>517-519</pages><co_aut>et al.</co_aut></literature><literature><id>971</id><title>[Segawa disease]</title><author>Nomura Y</author><journal>Rinsho Shinkeigaku</journal><year>1997</year><book /><volume>37</volume><number>12</number><pages>1137-1138</pages><co_aut /></literature><literature><id>1013</id><title>Molecular genetics of hereditary dystonie -- mutations in the GTP cyclohydrolase I gene</title><author>Ichinose H</author><journal>Brain Res Bull</journal><year>1997</year><book /><volume>43</volume><number>0</number><pages>35-38</pages><co_aut>Nagatsu T</co_aut></literature><literature><id>691</id><title>GTP cyclohydrolase I gene in hereditary progressive dystonia with diurnal fluctuation</title><author>Ichinose H</author><journal>Neurosci Lett</journal><year>1995</year><book /><volume>196</volume><number>0</number><pages>5-8</pages><co_aut>et al.</co_aut></literature><literature><id>697</id><title>Characterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiency</title><author>Ichinose H</author><journal>J Biol Chem</journal><year>1995</year><book /><volume>270</volume><number>0</number><pages>10062-71</pages><co_aut>et al.</co_aut></literature><literature><id>698</id><title>The gene for hereditary progressive dystonia with marked diurnal fluctuations maps to chromosom 14q</title><author>Tanaka H</author><journal>Ann Neurol</journal><year>1995</year><book /><volume>37</volume><number>3</number><pages>405-408</pages><co_aut>et al.</co_aut></literature><literature><id>696</id><title>Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GPT cyclohydrolase I gene</title><author>Ichinose H</author><journal>Nat Genet</journal><year>1994</year><book /><volume>8</volume><number>3</number><pages>236-242</pages><co_aut>et al.</co_aut></literature><literature><id>700</id><title>Hereditary progressive dystonia with marked diurnal fluctuation (Segawa syndrome) in Taiwan</title><author>Wang PJ</author><journal>Brain Dev</journal><year>1994</year><book /><volume>16</volume><number>2</number><pages>126-131</pages><co_aut>et al.</co_aut></literature><literature><id>699</id><title>Hereditary progressive dystonia with marked diurnal fluctuations</title><author>Segawa M</author><journal>Adv Neurol</journal><year>1976</year><book /><volume>14</volume><number>0</number><pages>215-233</pages><co_aut>et al.</co_aut></literature><literature><id>3208</id><title>Physicians Guide to the Laboratory Diagnosis of Metabolic Diseases</title><author>Blau N</author><journal>Springer</journal><year>0</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature></Literatures></Disease>